Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02273 固生堂
Listing Date2021/12/10
Listing Price29.000
Subscription Result
  • Subscription Rate
  • Guarantee One Lot Size
    2 lot
  • One Lot Success Rate

Gushengtang Holdings Limited is a TCM healthcare service provider in China. Through its offline medical institutions and online healthcare platforms, it provides customers with a comprehensive range of TCM healthcare services and products.

Since the establishment of the first TCM medical institution in Beijing in 2011, the Group have come to own and operate 42 medical institutions in Beijing, Shanghai, Guangzhou, Shenzhen, Foshan, Zhongshan, Fuzhou, Nanjing, Suzhou, Ningbo and Wuxi. They are operated under its brand name “Gushengtang”. In addition, it owned and operated a variety of online channels, including official websites in the name of both “Gushengtang” and “Bailu”.

The Group healthcare services include pre-consultation preparations, high-quality consultation and diagnosis, physiotherapies, TCM prescription and decocting services, and healthcare products.

MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot100
No. of Offer Shares27.88M shares
No. of International Offer Shares25.09M shares
No. of HK Offer Shares2.79M shares
Offer Price$25.80 - $29.00
Stock Code2273
Sponsor(s)Haitong International Capital Limited, Merrill Lynch (Asia Pacific) Limited
Underwriter(s)Merrill Lynch (Asia Pacific) Limited, Haitong International Securities Company Limited, China International Capital Corporation Hong Kong Securities Limited, GF Securities (Hong Kong) Brokerage Limited, ICBC International Securities Limited, Futu Securities International (Hong Kong) Limited, Sinomax Securities Limited
Application PeriodNov 30 (Tue) - noon, Dec 03 (Fri)
Price Determination DateDec 03 (Fri)
Result Announcement DateOn or before Dec 09 (Thu)
Result Announcement DateOn or before Dec 09 (Thu)
Dealings in Shares commence onDec 10, 2021. (Fri)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription15X - 50X50X - 100XOver 100X
% of total shares reallocated to HK Offer30%40%50%
Sales Statistics (HKD)
Offer Price$25.80 - $29.00
Capitalization5.94B - 6.68B
NAV / share ($)$3.58 - $3.95 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 27.40, the net proceeds raised would be HKD 663.10M, of which
69.8% : expand offline and online operations
9.6% : enhance research and development capabilities
9.6% : strengthen supply chain capability
4.9% : marketing and branding activities
6% : working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2022 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.